IDEAYA Biosciences, Inc.
IDYA
$19.13
$0.552.96%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 145.28% | 4.80% | |||
| Gross Profit | -133.03% | -4.80% | |||
| SG&A Expenses | 12.46% | -6.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 125.94% | 3.03% | |||
| Operating Income | -115.48% | -3.03% | |||
| Income Before Tax | -151.47% | 1.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -151.47% | 1.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -151.47% | 1.80% | |||
| EBIT | -115.48% | -3.03% | |||
| EBITDA | -116.49% | -3.13% | |||
| EPS Basic | -148.13% | 11.17% | |||
| Normalized Basic EPS | -192.36% | 11.18% | |||
| EPS Diluted | -148.13% | 11.17% | |||
| Normalized Diluted EPS | -192.36% | 11.18% | |||
| Average Basic Shares Outstanding | 1.34% | 10.55% | |||
| Average Diluted Shares Outstanding | 1.34% | 10.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
